United States · FDA National Drug Code directory
Trezix
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63187-705_cf14c5ce-0aa3-4511-9db0-7d5aa995f04d
- Product NDC
- 63187-705
- Form
- CAPSULE
- Composition / generic term
- acetaminophen, caffeine, dihydrocodeine bitartrate
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141201
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAMINOPHEN — 320.5 mg/1
- CAFFEINE — 30 mg/1
- DIHYDROCODEINE BITARTRATE — 16 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (63187-705-00) · 63187-705-00
- 30 CAPSULE in 1 BOTTLE (63187-705-30) · 63187-705-30
- 60 CAPSULE in 1 BOTTLE (63187-705-60) · 63187-705-60
- 120 CAPSULE in 1 BOTTLE (63187-705-72) · 63187-705-72
- 90 CAPSULE in 1 BOTTLE (63187-705-90) · 63187-705-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →